Investigation of hypothalamo-pituitary-gonadal axis and glucose intolerance among the first-degree female relatives of women with polycystic ovary syndrome

Fertility and Sterility

Volumn 87, Issue 6, 2007, Pages 1377-1382

  Ünlühizarci, Kürşad ^a   Özocak, Mehtap ^a   Tanriverdi, Fatih ^a   Atmaca, Hulusi ^b   Keleştimur, Fahrettin ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

^b Zonguldak Karaelmas Universitesi Tip Fakultesi   (Turkey)

Author keywords

first degree relative; Glucose intolerance; PCOS

Indexed keywords

BUSERELIN; ESTRADIOL; FOLLITROPIN; HYDROXYPROGESTERONE; LUTEINIZING HORMONE;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HORMONE BLOOD LEVEL; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESPONSE; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; OUTPATIENT; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RELATIVE; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; FAMILY; FEMALE; GLUCOSE INTOLERANCE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INSULIN; PITUITARY-ADRENAL SYSTEM; POLYCYSTIC OVARY SYNDROME; PREMENOPAUSE;

EID: 34249687212     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.11.075     Document Type: Article

References (31)

1. Ovalle F., and Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil Steril 77 (2002) 1091-1105
2. Ehrmann D.A., Liljenquist D.R., Kasza K., Azziz R., Legro R.S., Ghazzi M.N., and PCOS/Troglitazone Study Group. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 91 (2006) 41-53
3. Caballero A.E. Metabolic and vascular abnormalities in subjects at risk for type 2 diabetes: the early start of a dangerous situation. Arch Med Res 36 (2005) 241-249
4. Ehrmann D.A., Barnes R.B., Rosenfield R.L., Cavaghan M.K., and Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diab Care 22 (1999) 141-146
5. Unluhizarci K., Colak R., Sahin Y., Bayram F., and Keletimur F. The prevalance of glucose intolerance in women with polycystic ovary syndrome. Turk J Endocrinol Metab 4 (2000) 131-137
6. Legro R.S., Gnatuk C.L., Kunselman A.R., and Dunaif A. Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study. J Clin Endocrinol Metab 90 (2005) 3231-3242
7. Legro R.S., Driscoll D., Strauss J.F., Fox J., and Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci U S A 95 (1998) 14951-14960
8. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome. Fertil Steril 81 (2004) 11-25
9. Hatch R., Rosenfield R.L., Kim M.H., and Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 140 (1981) 811-830
10. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and cllassification of diabetes mellitus. Diab Care 21 Suppl 1 (1998) S5-S19
11. Bonora E., Targher G., Alberiche M., Bonadonna R.C., Saggiani F., Zenere M.B., et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diab Care 23 (2000) 51-63
12. Vrbikova J., Bendlova B., Hill M., Vankova M., Vondra K., and Starka L. Insulin sensitivity and β cell function in women with polycystic ovary syndrome. Diab Care 25 (2002) 1211-1222
13. Sahin Y., and Kelestimur F. 17-Hydroxyprogesterone response to buserelin testing in the polycystic ovary syndrome. Clin Endocrinol 39 (1993) 151-155
14. Ehrmann D.A., Barnes R.B., and Rosenfield R.L. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to a dysregulation of androgen secretion. Endocr Rev 16 (1995) 321-353
15. Franks S., Gharani N., Waterworth D., Batty S., White D., Williamson D., et al. The genetic basis of polycystic ovary syndrome. Hum Reprod 12 (1997) 2641-2648
16. Lunde O., Magnus P., Sandvik L., and Hoglo S. Familial clustering in polycystic ovary syndrome. Gynecol Obstet Invest 28 (1989) 21-30
17. Sir-Petermann T., Angel B., Maliqueo M., Carvajal F., Santos L., and Perez-Bravo F. Prevalence of type 2 diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome. Diabetologia 45 (2002) 951-964
18. Norman R.J., Masters S., and Hague W. Hyperinsulinemia is common in family members of women with polycystic ovary syndrome. Fertil Steril 66 (1996) 941-947
19. Dunaif A., Xia J., Book C.B., Schenker E., and Tang Z. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest 96 (1995) 801-810
20. Yilmaz M., Bukan N., Ersoy R., Karakoc A., Yetkin I., Ayvaz G., et al. Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome. Hum Reprod 20 (2005) 2411-2420
21. Yildiz B.O., Yarali H., Oguz H., and Bayraktar M. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. J Clin Endocrinol Metab 88 (2003) 2031-2036
22. Colila S., Cox N.J., and Ehrmann D. Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives. J Clin Endocrinol Metab 86 (2001) 2021-2031
23. Baker B., Mandarino L., Brick B., Rizza R., and Gerich J. Influence of changes in insulin receptor binding during insulin infusions on the shape of the insulin dose-response curve for glucose disposal in man. J Clin Endocrinol Metab 58 (1984) 391-396
24. Holte J., Bergh T., Berne C., Berglund L., and Lithell H. Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome. J Clin Endocrinol Metab 78 (1994) 1051-1058
25. Holte J., Bergh T., Berne C., Wide L., and Lithell H. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 80 (1995) 2581-2593
26. Kashar-Miller M.D., Nixon C., Boots L.R., Go R.C., and Azziz R. Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertil Steril 75 (2001) 51-58
27. Ibanez L., Hall J.E., Potau N., Carrascosa A., Prat N., and Taylor A.E. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GNRH agonist and human chorionic gonadotropin stimulating testing. J Clin Endocrinol Metab 81 (1996) 4101-4107
28. Barnes R.B., Rosenfield R.L., Burstein S., and Ehrmann D.A. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N Engl J Med 320 (1989) 551-565
29. Suikkari A.M., McLachlan V., Montalto J., Calderon I., Healy D.L., and McLachlan R.I. Ultrasonographic appearance of polycystic ovaries is assocaited with exaggerated ovarian androgen and oestradiol responses to gonadotrophin-releasing hormone agonist in women undergoing assisted reproduction treatment. Hum Reprod 10 (1995) 511-519
30. Fulghesu A.M., Villa P., Pavone V., Guido M., Apa R., Caruso A., et al. The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome. J Clin Endocrinol Metab 82 (1997) 641-648
31. De Leo V., La Marca A., Ditto A., Morgante G., and Cianci A. Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome. Fertil Steril 72 (1999) 281-285